InterventionsHuman trial
Results of a double‐blind sham‐controlled trial examining the effects of hyperbaric oxygen therapy on cognition and brain biomarkers
AAIC 2025 Abstract
Abstract
Background: Older adults with type 2 diabetes (T2D) and mild cognitive impairment (MCI) are at increased risk for dementia. Hyperbaric oxygen therapy (HBOT) has shown vascular and metabolic effects that may benefit brain health.
The paper
Ori Benari, Ramit Ravona‐Springer, Lan Luo, Michal Schnaider Beeri
Show 12 more authors
Liangyuan Hu, Y. Mardor, Orit H. Lesman‐Segev, Sapir Golan, Abigail Livny, Maayan Harel, Ganit Almog, Shai Efrati, Amir Hadanny, Roy Sagi, Barbara B. Bendlin, Mary Sano,Tel Aviv University · Herbert and Jacqueline Krieger Klein Alzheimer’s Research Center
AAIC 2025 Abstract · 23 Dec 2025 · CC BY
Presented at AAIC 2025
